BioLife Solutions, Inc. Fair Value Adjustment of Warrants
BioLife Solutions, Inc. (BLFS) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-02-29
- BioLife Solutions, Inc. fair value adjustment of warrants for the quarter ending 2022-12-31 was $0.00.
- BioLife Solutions, Inc. fair value adjustment of warrants for the quarter ending 2022-09-30 was $0.00.
- BioLife Solutions, Inc. fair value adjustment of warrants for the quarter ending 2022-06-30 was $0.00.
- BioLife Solutions, Inc. fair value adjustment of warrants for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. fair value adjustment of warrants for fiscal 2023 was $0.00.
- BioLife Solutions, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BioLife Solutions, Inc. fair value adjustment of warrants for fiscal 2021 was $121.00K.
- BioLife Solutions, Inc. fair value adjustment of warrants for fiscal 2020 was -$3.60M, a 128.06% decline from fiscal 2019.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $121.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $121.00K 10-Q · filed 2022-11-09 | $987.00K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $121.00K 10-Q · filed 2022-08-09 | $987.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.99M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-03-31 | $121.00K 10-Q · filed 2022-05-10 | $987.00K derived: sum of 2 quarters · filed 2023-03-31 | $1.99M derived: sum of 3 quarters · filed 2023-03-31 | $18.43M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2020-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.87M derived: sum of 2 quarters · filed 2023-03-31 | $18.31M derived: sum of 3 quarters · filed 2023-03-31 | -$3.60M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-15 | $17.45M derived: sum of 2 quarters · filed 2021-11-15 | -$4.47M 10-Q · filed 2021-11-15 | -$6.58M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-06-30 | $16.44M 10-Q · filed 2021-08-16 | -$5.47M 10-Q · filed 2021-08-16 | -$7.59M derived: sum of 3 quarters · filed 2022-03-31 | -$8.71M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-03-31 | -$21.91M 10-Q · filed 2021-05-17 | -$24.03M derived: sum of 2 quarters · filed 2022-03-31 | -$25.16M derived: sum of 3 quarters · filed 2022-03-31 | -$28.74M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2019-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$3.24M derived: sum of 2 quarters · filed 2022-03-31 | -$6.83M derived: sum of 3 quarters · filed 2022-03-31 | $12.84M 10-K · filed 2022-03-31 | |
| 2019-09-30 | -$1.13M 10-Q · filed 2020-11-09 | $1.13M 10-K · filed 2020-05-15 | -$4.71M derived: sum of 2 quarters · filed 2020-11-09 | $14.95M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$3.59M 10-Q · filed 2020-08-10 | $3.59M 10-K · filed 2020-05-15 | $16.08M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $19.66M 10-Q · filed 2020-05-29 | ||||
| 2019-03-30 | $19.66M 10-K · filed 2020-05-15 | -$377.00K derived: sum of 2 quarters · filed 2020-05-15 | $25.32M derived: sum of 3 quarters · filed 2020-05-15 | $52.80M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | -$20.04M derived: 10-K 12 month − 10-K 9 month · filed 2020-05-15 | $5.66M derived: sum of 2 quarters · filed 2020-05-15 | $33.14M derived: sum of 3 quarters · filed 2020-05-15 | $28.27M 10-K · filed 2020-05-15 | |
| 2018-09-30 | $25.70M 10-K · filed 2020-05-15 | $53.18M derived: sum of 2 quarters · filed 2020-05-15 | $48.31M 10-K · filed 2020-05-15 | ||
| 2018-06-30 | $27.48M 10-K · filed 2020-05-15 | $22.61M 10-K · filed 2020-05-15 | |||
| 2018-03-31 | $4.87M 10-K · filed 2020-05-15 | ||||
| 2018-03-30 | -$4.87M 10-K · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |